The ruthenium(II) complex cis-[RuCl 2 (dmso) 4 ] is known for its antiproliferative properties. This has stimulated the discovery of a wide group of new ruthenium complexes considered as potential anticancer drugs. The stability of these ruthenium complexes under physiological conditions and their interaction with protein amino acid residues are particularly important because of their intravenous administration. The studies presented here are devoted to the stability of cis-[RuCl 2 (dmso) 4 ] under physiological pH conditions and its reactivity towards L-methionine. Immediate dissociation of one dmso ligand from the parent complex after dilution in water leads to the formation of fac-[RuCl 2 -(H 2 O)(dmso) 3 ], which under basic conditions undergoes step-[a] Faculty